Loading
  • Cortisol Modulation
  • Stories
  • Careers
  • Contact
  • Home
  • About
    • Our Team
  • Products
    • Medical Information Request
  • Science
    • Pipeline and Clinical Trials
    • Cortisol Modulation
    • Therapeutic Areas
    • Publications
    • Investigator Initiated Studies
  • Resources
    • Grants
    • Compassionate use
    • State Required Notice
  • Investors
    • Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Search
  • Menu Menu
  • Home
  • About
    • Teams
  • Products
    • Medical Information Request
  • Science
    • Pipeline and Clinical Trials
    • Cortisol Modulation
    • Therapeutic Areas
    • Publications
    • Investigator Initiated Studies
  • Resources
    • Grants
    • Compassionate use
    • State Required Notice
  • Stories
  • Careers
  • Contact
  • Investors
    • Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Privacy Notice
  • Terms of Use
  • Site Map

The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.

September 19, 2018

Beebe et al. • 2006 • Behav Brain Res. 2006;171(2):225-9.

Read more
https://corcept.com/wp-content/uploads/COR-logo.svg 0 0 jeremiah@devisedesigns.com https://corcept.com/wp-content/uploads/COR-logo.svg jeremiah@devisedesigns.com2018-09-19 00:00:002018-09-19 00:00:00The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.

Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.

September 19, 2018

Gross et al. • 2010 • Obesity (Silver Spring). 2010;18(12):2295-300.

Read more
https://corcept.com/wp-content/uploads/COR-logo.svg 0 0 jeremiah@devisedesigns.com https://corcept.com/wp-content/uploads/COR-logo.svg jeremiah@devisedesigns.com2018-09-19 00:00:002018-09-19 00:00:00Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.

Mifepristone treatment of olanzapine-induced weight gain in healthy men.

September 19, 2018

Gross et al. • 2009 • Adv Ther. 2009;26(10):959-69.

Read more
https://corcept.com/wp-content/uploads/COR-logo.svg 0 0 jeremiah@devisedesigns.com https://corcept.com/wp-content/uploads/COR-logo.svg jeremiah@devisedesigns.com2018-09-19 00:00:002018-09-19 00:00:00Mifepristone treatment of olanzapine-induced weight gain in healthy men.

The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness.

September 21, 2017

Moraitis et al. • 2017 • J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):114-120.

Read more
https://corcept.com/wp-content/uploads/COR-logo.svg 0 0 jeremiah@devisedesigns.com https://corcept.com/wp-content/uploads/COR-logo.svg jeremiah@devisedesigns.com2017-09-21 00:00:002024-03-15 21:57:07The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness.
Page 3 of 3123

Categories

  • Endocrinology
  • Hypercortisolism (Cushing syndrome)
  • Metabolism
  • Neurology
  • Oncology
  • Other
  • Uncategorized

© 2024 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Privacy Notice

Terms of Use

Site Map

Your Privacy Choices

LinkedIn

Youtube

Scroll to top